PROCEEDINGS VOLUME 2078
EUROPTO BIOMEDICAL OPTICS '93 | 29 AUGUST - 3 SEPTEMBER 1993
Photodynamic Therapy of Cancer
EUROPTO BIOMEDICAL OPTICS '93
29 August - 3 September 1993
Budapest, Hungary
Photosensitizers for photodynamic therapy of tumors
Proc. SPIE 2078, New photosensitizers for the photodynamic therapy of tumors, 0000 (1 March 1994); doi: 10.1117/12.168648
Proc. SPIE 2078, Photodynamic therapy of malignancies with benzoporphyrin derivative monoacid ring A, 0000 (1 March 1994); doi: 10.1117/12.168659
Proc. SPIE 2078, Phthalocyanines as photosensitizing agents for tumors--mechanism of action, 0000 (1 March 1994); doi: 10.1117/12.168667
Proc. SPIE 2078, CGP 55 847, liposome-delivered zinc(II)-phthalocyanine as a phototherapeutic agent for tumors, 0000 (1 March 1994); doi: 10.1117/12.168675
Proc. SPIE 2078, Prospects of radical-interacting porphyrin photosensitizers and their possible use in photodynamic therapy, 0000 (1 March 1994); doi: 10.1117/12.168684
Proc. SPIE 2078, Utilization of 5-aminolevulinic acid in the photodynamic therapy of tumors: biochemical and photobiological aspects, 0000 (1 March 1994); doi: 10.1117/12.168693
Photodynamic Therapy I
Proc. SPIE 2078, Possibilities and limitations in chemical modeling of the primary processes in photodynamic therapy, 0000 (1 March 1994); doi: 10.1117/12.168702
Proc. SPIE 2078, Photodynamic laser therapy with antibody-coupled phthalocyanine, 0000 (1 March 1994); doi: 10.1117/12.168709
Proc. SPIE 2078, Synthesis and biological evaluation of a series of new germanium phthalocyanines incorporated into liposomes--part I: chemistry, 0000 (1 March 1994); doi: 10.1117/12.168716
Proc. SPIE 2078, Synthesis and biological evaluation of a series of new germanium phthalocyanines incorporated into liposomes--part II: biological evaluation, 0000 (1 March 1994); doi: 10.1117/12.168649
Proc. SPIE 2078, Photodynamic therapy photosensitizers derived from chlorophyll a, 0000 (1 March 1994); doi: 10.1117/12.168650
Proc. SPIE 2078, Time-resolved fluorescence spectroscopy of ether-bonded porphyrin-chlorin dimer, 0000 (1 March 1994); doi: 10.1117/12.168651
Proc. SPIE 2078, New sensitizers for diagnosis and photodynamic therapy of malignant tissues, 0000 (1 March 1994); doi: 10.1117/12.168652
Proc. SPIE 2078, Bacteriopheophorbide esters: photosensitizers without "threshold dose"?, 0000 (1 March 1994); doi: 10.1117/12.168653
Proc. SPIE 2078, In vivo uptake and photodynamic activity of porphycenes, 0000 (1 March 1994); doi: 10.1117/12.168654
Proc. SPIE 2078, In vitro photosensitizing activity of benzoporphyrin derivative monoacid ring A using pulsed and continuous-wave irradiation, 0000 (1 March 1994); doi: 10.1117/12.168655
Proc. SPIE 2078, Biodistribution detection of Photofrin porfimer sodium and benzoporphyrin derivative using a fiber optic sensor and ratio fluorometry, 0000 (1 March 1994); doi: 10.1117/12.168656
Proc. SPIE 2078, Liposome-administered tetramethylhematoporphyrin (TMHP) as a photodynamic agent, 0000 (1 March 1994); doi: 10.1117/12.168657
Proc. SPIE 2078, Direct phosphorescent detection of primary event of photodynamic action, 0000 (1 March 1994); doi: 10.1117/12.168658
Interactions of photodynamic sensitizers with cells and tissues
Proc. SPIE 2078, Transport modalities of photodynamic agents for tumors, 0000 (1 March 1994); doi: 10.1117/12.168660
Proc. SPIE 2078, Subcellular distribution of photodynamic sensitizers, 0000 (1 March 1994); doi: 10.1117/12.168661
Proc. SPIE 2078, Effect of sulfonation on the photosensitizing efficiency of aluminum phthalocyanine and meso-tetraphenylporphine in photodynamic therapy of cancer, 0000 (1 March 1994); doi: 10.1117/12.168662
Proc. SPIE 2078, Immunopharmacology studies on photosensitizers used in photodynamic therapy, 0000 (1 March 1994); doi: 10.1117/12.168663
Mechanisms of cells/tissue damage
Proc. SPIE 2078, Cellular responses to photodynamic therapy, 0000 (1 March 1994); doi: 10.1117/12.168664
Proc. SPIE 2078, Responses of tumor tissues to photodynamic therapy, 0000 (1 March 1994); doi: 10.1117/12.168665
Proc. SPIE 2078, Nononcologic potentials for photodynamic therapy, 0000 (1 March 1994); doi: 10.1117/12.168666
Proc. SPIE 2078, Antimicrobial and antiviral activity of porphyrin photosensitization, 0000 (1 March 1994); doi: 10.1117/12.168668
Proc. SPIE 2078, Merocyanine 540 and Photofrin II as photosensitizers for in vitro killing of duck hepatitis B virus and human hepatoma cells, 0000 (1 March 1994); doi: 10.1117/12.168669
Proc. SPIE 2078, Photochemical inactivation of viruses by antibody conjugates of compounds generating singlet oxygen, 0000 (1 March 1994); doi: 10.1117/12.168670
Indications for photodynamic therapy of tumors
Proc. SPIE 2078, Preliminary clinical studies of PDT with meso-tetrahydroxyphenyl chlorin (m-THPC) as a photosensitizing agent for the treatment of early pharyngeal, esophageal, and bronchial carcinomas, 0000 (1 March 1994); doi: 10.1117/12.168671
Proc. SPIE 2078, Photodynamic therapy of gastrointestinal cancers, 0000 (1 March 1994); doi: 10.1117/12.168672
Proc. SPIE 2078, Present status of photodynamic procedures in urology, 0000 (1 March 1994); doi: 10.1117/12.168673
Proc. SPIE 2078, Induction of protoporphyrin biosynthesis and photodynamic inactivation of B16 melanoma cells, 0000 (1 March 1994); doi: 10.1117/12.168674
Proc. SPIE 2078, Kinetic and localization properties of protoporphyrin dimethyl ester in fibrosarcoma cells, 0000 (1 March 1994); doi: 10.1117/12.168676
Photodynamic Therapy II
Proc. SPIE 2078, Photodynamic therapy using aminolevulinic acid (ALA), 0000 (1 March 1994); doi: 10.1117/12.168677
Proc. SPIE 2078, Uptake of zinc(II)-phthalocyanine by HepG2 cells expressing the low-density lipoprotein receptor: studies with the liposomal formulation CGP55847, 0000 (1 March 1994); doi: 10.1117/12.168678
Proc. SPIE 2078, Distribution of photosensitizers between tumor cells and tumor infiltrating host cells, 0000 (1 March 1994); doi: 10.1117/12.168679
Proc. SPIE 2078, Pharmaceutical development of CGP 55847: a liposomal Zn-phthalocyanine formulation using a controlled organic solvent dilution method, 0000 (1 March 1994); doi: 10.1117/12.168680
Proc. SPIE 2078, Kinetics of the photodynamic damage of phthalocyanine-loaded cultured K562 cells studied by means of flow cytometry, 0000 (1 March 1994); doi: 10.1117/12.168681
Proc. SPIE 2078, Evaluation of prostatic optical properties and tissue response to photodynamic therapy in a canine model, 0000 (1 March 1994); doi: 10.1117/12.168682
Proc. SPIE 2078, Is the photobleaching signal a useful tool for dosimetry during photodynamic therapy?, 0000 (1 March 1994); doi: 10.1117/12.168683
Proc. SPIE 2078, Pharmakokinetics of 132-hydroxy-bacteriopheophorbide: a methyl ester studied by fluorescence spectroscopy on Lewis lung carcinoma bearing mice, 0000 (1 March 1994); doi: 10.1117/12.168685
Proc. SPIE 2078, Photodynamic tumor therapy and on-line fluorescence spectroscopy after aminolevulinic acid administration using 633-nm light as therapeutic and fluorescence excitation radiation, 0000 (1 March 1994); doi: 10.1117/12.168686
Proc. SPIE 2078, Radiosensitization by porphyrins in 60Co-irradiated cells of different natures, 0000 (1 March 1994); doi: 10.1117/12.168687
Poster Session
Proc. SPIE 2078, Synthesis of axially disubstituted octakis-alkoxy-germanium(IV) phthalocyanines, 0000 (1 March 1994); doi: 10.1117/12.168688
Proc. SPIE 2078, Fluorescence resonance energy transfer measurements as a tool to detect fusion and drug exchange in liposomal suspensions, 0000 (1 March 1994); doi: 10.1117/12.168689
Proc. SPIE 2078, Time-resolved fluorescence spectroscopy of tetrasulfonated aluminum phthalocyanine in solution and cells, 0000 (1 March 1994); doi: 10.1117/12.168690
Proc. SPIE 2078, Photophysics of sulphonated aluminum phthalocyanines in reversed micelles, 0000 (1 March 1994); doi: 10.1117/12.168691
Proc. SPIE 2078, Photodynamic therapy: light dosimetry and laser-induced tissue temperature phenomena, 0000 (1 March 1994); doi: 10.1117/12.168692
Proc. SPIE 2078, Perspectives of obtaining photosensitizers for near-IR range, 0000 (1 March 1994); doi: 10.1117/12.168694
Proc. SPIE 2078, Photodynamic therapy of cancer by photogem, 0000 (1 March 1994); doi: 10.1117/12.168695
Proc. SPIE 2078, Efficiency of photodynamic therapy under pulsed laser radiation: model investigations, 0000 (1 March 1994); doi: 10.1117/12.168696
Proc. SPIE 2078, New liposome-bound Ge(IV)-phthalocyanine (CGP 55398) for photodynamic therapy of tumors: preliminary studies, 0000 (1 March 1994); doi: 10.1117/12.168697
Proc. SPIE 2078, Investigation of photodynamic processes with laser, 0000 (1 March 1994); doi: 10.1117/12.168698
Proc. SPIE 2078, Meso-tetra (4-carboxyphenyl) porphyrin--fluorescence behavior, photodynamic treatment, and tissue distribution, 0000 (1 March 1994); doi: 10.1117/12.168699
Proc. SPIE 2078, Synthesis of some water soluble diphthalocyanines of rare earth elements as perspective synthetic PDT dyes, 0000 (1 March 1994); doi: 10.1117/12.168700
Proc. SPIE 2078, Synthesis and properties of sulphonated phthalocyanines of IV group elements as possible new dyes for PDT of cancer, 0000 (1 March 1994); doi: 10.1117/12.168701
Proc. SPIE 2078, Investigation of therapeutics width in treatment of experimental cancer used by the model of medicine based on photosensitizer of second generation for PDT--aluminum sulfonated phthalocyanine, 0000 (1 March 1994); doi: 10.1117/12.168703